274 related articles for article (PubMed ID: 28317318)
1. Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study.
Bossen L; Grønbaek H; Lykke Eriksen P; Jepsen P
Liver Int; 2017 Jul; 37(7):1042-1046. PubMed ID: 28317318
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma arising in a telangiectatic hepatocellular adenoma.
González-Lara MF; Córdova-Ramón JC; Gamboa-Domínguez A; Cosme-Labarthe J; Carrillo-Pérez DL
Ann Hepatol; 2013; 12(4):626-8. PubMed ID: 23813141
[TBL] [Abstract][Full Text] [Related]
3. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis.
Jepsen P; Kraglund F; West J; Villadsen GE; Sørensen HT; Vilstrup H
J Hepatol; 2020 Nov; 73(5):1030-1036. PubMed ID: 32512015
[TBL] [Abstract][Full Text] [Related]
4. Malignant transformation of hepatocellular adenoma over a decade.
Tokoro T; Kato Y; Sugioka A; Mizoguchi Y
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25246462
[TBL] [Abstract][Full Text] [Related]
5. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study.
Jepsen P; Andersen MW; Villadsen GE; Ott P; Vilstrup H
Liver Int; 2017 Jun; 37(6):871-878. PubMed ID: 27943604
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study.
Grønbæk L; Vilstrup H; Jepsen P
J Hepatol; 2014 Mar; 60(3):612-7. PubMed ID: 24326217
[TBL] [Abstract][Full Text] [Related]
7. Changing trends in malignant transformation of hepatocellular adenoma.
Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
[TBL] [Abstract][Full Text] [Related]
8. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study.
Jepsen P; Ott P; Andersen PK; Sørensen HT; Vilstrup H
Ann Intern Med; 2012 Jun; 156(12):841-7, W295. PubMed ID: 22711076
[TBL] [Abstract][Full Text] [Related]
9. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F
Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
[TBL] [Abstract][Full Text] [Related]
10. A case of hepatocellular carcinoma within hepatocellular adenoma in a non-cirrhotic male.
Kim DH; Kim SU; Nam DH; Choi YJ; Park SM; Lee CK; Kim DY
Korean J Intern Med; 2009 Jun; 24(2):147-52. PubMed ID: 19543495
[TBL] [Abstract][Full Text] [Related]
11. Liver cell adenoma with concomitant hepatocellular carcinoma: report of two cases.
Chuang WY; Chen TC; Hsu HL; Lee WC; Jeng LB; Huang SF
J Formos Med Assoc; 2002 Nov; 101(11):798-802. PubMed ID: 12517062
[TBL] [Abstract][Full Text] [Related]
12. [Malignant transformation of hepatocellular adenoma in men].
Goudard Y; Rouquie D; Bertocchi C; Daligand H; Baton O; Lahutte M; Terris B; Baranger B
Gastroenterol Clin Biol; 2010 Mar; 34(3):168-70. PubMed ID: 20189337
[No Abstract] [Full Text] [Related]
13. European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group.
Laurent A; Dokmak S; Nault JC; Pruvot FR; Fabre JM; Letoublon C; Bachellier P; Capussotti L; Farges O; Mabrut JY; Le Treut YP; Ayav A; Suc B; Soubrane O; Mentha G; Popescu I; Montorsi M; Demartines N; Belghiti J; Torzilli G; Cherqui D; Hardwigsen J;
HPB (Oxford); 2016 Sep; 18(9):748-55. PubMed ID: 27593592
[TBL] [Abstract][Full Text] [Related]
14. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
15. [Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].
Herman P; Machado MA; Volpe P; Pugliese V; Vianna MR; Bacchella T; Machado MC; Pinotti HW
Rev Hosp Clin Fac Med Sao Paulo; 1994; 49(1):30-3. PubMed ID: 8029613
[TBL] [Abstract][Full Text] [Related]
16. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
[TBL] [Abstract][Full Text] [Related]
17. [Liver resection and liver transplantation in liver cell adenoma, hepatocellular carcinoma and fibrolamellar liver carcinoma].
Lang H; Dömland M; Broelsch CE
Praxis (Bern 1994); 2001 Jan; 90(1-2):7-13. PubMed ID: 11206098
[TBL] [Abstract][Full Text] [Related]
18. Clinical features in hepatocellular carcinoma and the impact of autopsy on diagnosis. A study of 530 cases from a low-endemicity area.
Kaczynski J; Hansson G; Wallerstedt S
Hepatogastroenterology; 2005; 52(66):1798-802. PubMed ID: 16334780
[TBL] [Abstract][Full Text] [Related]
19. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical Staining on an Excision Biopsy Specimen as a Diagnostic Modality for Rare Idiopathic Hepatocellular Adenoma: A Case Report.
Kurniawan J; Sanityoso A; Lalisang TJ; Krisnuhoni E; Matondang S; Araminta AP; Lutfie L
Acta Med Indones; 2019 Jan; 51(1):62-67. PubMed ID: 31073109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
